Skip to main content

Table 3 Correlation between AMH levels and some clinical and biochemical parameters. The number of pairs evaluated is reported in brackets

From: Cross-sectional and prospective study on anti-Müllerian hormone changes in a cohort of pre-menopausal women with a history of differentiated thyroid cancer

 

Group 1

Group 2

Group 3

Sr

P

Sr

P

Sr

P

Age

−0.71 (59)

< 0.0001

− 0.72 (30)

< 0.0001

− 0.62 (141)

< 0.0001

Years since diagnosis

− 0.20 (59)

0.14

0.03 (30)

0.89

n.a.

n.a.

RAI activity

−0.11 (59)

0.38

n.a.

n.a.

n.a.

n.a

BMI

0.02(59)

0.84

0.05 (30)

0.81

0.01 (132)

0.93

L-T4 dosage/week

0.13 (59)

0.32

−0.11 (30)

0.55

n.a

n.a

TSH

−0.04 (59)

0.78

0.16 (30)

0.40

0.14 (121)

0.12

f-T4

0.06 (59)

0.65

0.32 (30)

0.09

−0.13 (105)

0.19

Thyroglobulin

−0.05 (59)

0.78

0.04 (30)

0.81

n.a

n.a.

FSH

−0.55 (56)

< 0.0001

−0.77 (30)

< 0.0001

− 0.46 (102)

< 0.0001

Estradiol

−0.13 (54)

0.35

0.20 (28)

0.30

−0.16 (98)

0.12

Progesterone

0.28 (52)

0.05

0.28 (26)

0.16

−0.18 (85)

0.09

PRL

0.09 (57)

0.52

0.09 (26)

0.68

−0.11 (97)

0.26

  1. n.a. Not applicable